DK3642340T3 - Modificeret L-asparaginase - Google Patents

Modificeret L-asparaginase Download PDF

Info

Publication number
DK3642340T3
DK3642340T3 DK18731853.0T DK18731853T DK3642340T3 DK 3642340 T3 DK3642340 T3 DK 3642340T3 DK 18731853 T DK18731853 T DK 18731853T DK 3642340 T3 DK3642340 T3 DK 3642340T3
Authority
DK
Denmark
Prior art keywords
asparaginase
modified
Prior art date
Application number
DK18731853.0T
Other languages
English (en)
Inventor
Lars Friedrich
Anne O'donnell
Original Assignee
Jazz Pharmaceuticals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP17177237.9A external-priority patent/EP3418383A1/en
Priority claimed from US15/671,086 external-priority patent/US10174302B1/en
Application filed by Jazz Pharmaceuticals Ireland Ltd filed Critical Jazz Pharmaceuticals Ireland Ltd
Application granted granted Critical
Publication of DK3642340T3 publication Critical patent/DK3642340T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001—Asparaginase (3.5.1.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK18731853.0T 2017-06-21 2018-06-21 Modificeret L-asparaginase DK3642340T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762523061P 2017-06-21 2017-06-21
EP17177237.9A EP3418383A1 (en) 2017-06-21 2017-06-21 Modified l-asparaginase
US15/671,086 US10174302B1 (en) 2017-06-21 2017-08-07 Modified L-asparaginase
PCT/EP2018/066647 WO2018234492A1 (en) 2017-06-21 2018-06-21 L-ASPARAGINASE MODIFIED

Publications (1)

Publication Number Publication Date
DK3642340T3 true DK3642340T3 (da) 2024-06-03

Family

ID=64737515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18731853.0T DK3642340T3 (da) 2017-06-21 2018-06-21 Modificeret L-asparaginase

Country Status (15)

Country Link
EP (2) EP3642340B1 (da)
JP (2) JP7808424B2 (da)
KR (1) KR102727396B1 (da)
CN (1) CN111315878B (da)
AU (1) AU2018287145B2 (da)
BR (1) BR112019027479A2 (da)
CA (1) CA3068100A1 (da)
DK (1) DK3642340T3 (da)
ES (1) ES2979314T3 (da)
FI (1) FI3642340T3 (da)
IL (1) IL271504B2 (da)
MX (2) MX2019015502A (da)
SA (2) SA519410870B1 (da)
SG (1) SG11201912625QA (da)
WO (1) WO2018234492A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3394266T3 (pl) 2015-12-22 2021-12-13 Xl-Protein Gmbh Kwasy nukleinowe kodujące powtarzalne sekwencje aminokwasowe bogate w reszty proliny i alaniny, które mają sekwencje nukleotydowe o niskiej powtarzalności
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
KR102727396B1 (ko) * 2017-06-21 2024-11-08 재즈 파마슈티칼즈 아일랜드 리미티드 변형된 l-아스파라기나아제
WO2019101308A1 (en) * 2017-11-22 2019-05-31 Merz Pharma Gmbh & Co. Kgaa Novel recombinant botulinum toxin with increased duration of effect
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
AU2020371963A1 (en) * 2019-10-25 2022-05-26 Jazz Pharmaceuticals Ireland Ltd. Recombinant L-asparaginase
KR20230125179A (ko) * 2020-12-23 2023-08-29 재즈 파마슈티칼즈 아일랜드 리미티드 전하-차폐 융합 단백질의 정제 방법
US20220313798A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
WO2024015529A2 (en) 2022-07-14 2024-01-18 Jazz Pharmaceuticals Ireland Ltd. Combination therapies involving l-asparaginase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
GB8519753D0 (en) * 1985-08-06 1985-09-11 Health Lab Service Board Production of 1-asparaginase
GB9017002D0 (en) * 1990-08-02 1990-09-19 Health Lab Service Board Improved method for the purification of erwina l-asparaginase
WO2007103290A2 (en) 2006-03-03 2007-09-13 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Materials and methods directed to asparagine synthetase and asparaginase therapies
EP2137307B1 (en) * 2007-03-09 2014-07-30 Novozymes A/S Thermostable asparaginases
JP5351889B2 (ja) 2007-06-21 2013-11-27 テクニシェ ユニバーシタット ミュンヘン インビボおよび/またはインビトロ安定性が増大した生物学的に活性なタンパク質
WO2011003633A1 (en) * 2009-07-06 2011-01-13 Alize Pharma Ii Pegylated l-asparaginase
MX338914B (es) * 2010-05-21 2016-05-06 Xl Protein Gmbh Polipeptidos biosinteticos de espira aleatoria de prolina/alanina y sus usos.
CA2865578C (en) 2012-02-27 2023-01-17 Amunix Operating Inc. Xten conjugate compositions and methods of making same
KR102727396B1 (ko) * 2017-06-21 2024-11-08 재즈 파마슈티칼즈 아일랜드 리미티드 변형된 l-아스파라기나아제

Also Published As

Publication number Publication date
CN111315878A (zh) 2020-06-19
ES2979314T3 (es) 2024-09-25
SA519410870B1 (ar) 2023-03-06
SA522433360B1 (ar) 2024-06-23
IL271504A (en) 2020-02-27
MX2019015502A (es) 2020-07-28
BR112019027479A2 (pt) 2020-09-15
AU2018287145B2 (en) 2024-04-18
EP3642340B1 (en) 2024-03-20
KR20200030065A (ko) 2020-03-19
CA3068100A1 (en) 2018-12-27
RU2020101972A (ru) 2021-07-21
WO2018234492A1 (en) 2018-12-27
MX2024015050A (es) 2025-01-09
SG11201912625QA (en) 2020-01-30
JP2020528743A (ja) 2020-10-01
JP7770352B2 (ja) 2025-11-14
EP3642340A1 (en) 2020-04-29
IL271504B2 (en) 2024-05-01
CN111315878B (zh) 2024-04-26
RU2020101972A3 (da) 2021-11-09
IL271504B1 (en) 2024-01-01
JP7808424B2 (ja) 2026-01-29
AU2018287145A1 (en) 2020-02-06
KR102727396B1 (ko) 2024-11-08
JP2023081915A (ja) 2023-06-13
FI3642340T3 (fi) 2024-06-18
EP4180525A1 (en) 2023-05-17

Similar Documents

Publication Publication Date Title
DK3731771T3 (da) V462033dk00
CL2018000524S1 (es) Golilla
EP3589248A4 (en) CRYOTHERAPIES
DE202018003363U8 (de) Handgelenkssphygmomanometer
EP3634404C0 (en) PYRAZOLE-BASED MAGL INHIBITORS
EP3697802A4 (en) TRITERPENIC SAPONIN ANALOGUES
EP3588580A4 (en) SCHOTTKY MOS TRENCH DIODE
DK3351526T3 (da) Diisopentylterephthalat
EP3654852A4 (en) TOURNIQUET
EP3634397A4 (en) HETEROCYCLYL POLYMETHINE-BASED IR CHROMOPHORES
DK3568655T3 (da) Rekuperator
DK3571580T5 (da) Load-logical-and-shift-guarded-instruktion
EP3721165C0 (en) MILITARY CHARGE
DK3612237T3 (da) Genterapi
EP3611402A4 (en) SERVO CYLINDER
EP3615471A4 (en) PLASMA PHOTOELECTRONIC IMMUNE SENSOR
EP3684343C0 (en) IMPROVED SUPERPARTICLES
EP3669219C0 (en) NETWORK SCALE
EP3714787A4 (en) BIOSENSOR
EP3728590C0 (en) NEW THIOPHOSPHORAMIDITES
DK3576686T3 (da) Brokbind
DK3568506T3 (da) Offeranode
EP3689701A4 (en) BOGIE
EP3687383C0 (fr) Electrogustometre
DK3510051T3 (da) Carboxylalkylchitosan